Model agreements contain commentaries and, in many places, alternative wording is displayed in square brackets. You must choose which of the alternatives best suits your circumstances, if any, and all optional notes and forms must be removed before the agreement is prepared for signature. A team of specialists from international business firm Gowling WLG has been asked to provide legal advice as part of a consortium contract for the manufacture of breathing apparatus for the NHS. 1 Model consortium agreement for collaborative R&D projects with several partners This agreement is concluded on the day of the 200th time between the University of England and the UNIVERSITY OF NORTHERN IRELAND and the UNIVERSITY OF SCOTLAND and the UNIVERSITY OF WALES (hereinafter referred to as the separate party, collectively or as the contracting parties): – A. The Parties to this Agreement wish to implement a project entitled E-Learning Materials. B. The Parties intend to implement a programme of work described in Annex 1 [not attached] (hereinafter referred to as `the Project`). C. The annual project [ ] includes the development of [ ] and the production of [ ] (hereinafter referred to as deliverables). It is expected that deliverables can be developed after the end of the project and that such development can lead to the production of additional materials (hereinafter referred to as products).
This Agreement lays down the arrangements for relations between the Contracting Parties. It is agreed as follows:- 1. The objective of the consortium is to carry out the project and produce the results as described above. 2. Start and duration The consortium has been formed and the project has started from a date of entry into force and the project has a duration of [ ] years, unless the parties have not agreed otherwise in writing. 3. Project Resources The overall funding of the project is as follows: year 1 – [ ] year 2 – [ ] Year 3 – [ ] Total – [ ] The Gowling WLG team designed a first draft consortium agreement for The UK Fan Challenge and facilitated the development of the consortium agreement between 10 parties, including Ford, Penlon, Airbus, McLaren, HVM Catapult, Siemens plc, Siemens Healthineers, Renishaw, Ultra Electronics and Meggitt, as well as negotiations and agreements with the UK Government`s Cabinet Office. The goal is to make a production line that currently produces 60 respirators per week a production line capable of producing more than 1500 per week to meet the needs of the health sector. This activity was reversed in a very short time.
Dick Elsy, Managing Director of High Value Manufacturing Catapult, which leads the consortium, said: “This consortium brings together some of the most innovative companies in the world. Every day, their highly skilled employees work together to develop solutions that help millions of people, and this project is no different. They are collaborating with incredible determination and energy to accelerate the production of breathing apparatus they desperately need and fight a virus that is affecting people in many countries.